NYSEARCA:GERM
Delisted

Etfmg Treatments Testing And Advancements Etf ETF News

etoro logo Buy GERM
*Your capital is at risk
$19.16
+0 (+0%)
At Close: Dec 04, 2024

Biotech Innovations Remain At Forefront

11:10am, Friday, 16'th Apr 2021
The first quarter of 2021 was challenging for the biotechnology industry, as the selloff in March represented a sharp reversal from record highs in February. While the sector has remained relatively r

Moving Beyond COVID In Biopharma

09:31am, Thursday, 15'th Apr 2021
Just over one year after COVID-19 disrupted our lives, we are now getting to the point where multiple vaccine options are nearly ubiquitous for those in the United States. Per the CDC, as of April 12,
Covid-19 has put healthcare stocks in the limelight. These seven companies should be on your radar for the next pandemic.
The first half of 2021 is expected to continue bearing the brunt of the coronavirus outbreak considering the pandemic's renewed resurgence thanks to variants. Thus, a COVID-themed ETF could be a smart

6 ETF Areas That Are on High Momentum

09:06am, Tuesday, 02'nd Feb 2021
The first month of 2021 was pretty volatile. While stocks were at their all-time highs in first part of January, some downbeat economic data points as well as the retail trading frenzy in some specifi
The three indices logged in their worst week since October, dropping more than 3% each, sending the Dow Jones and S&P 500 into the red for the first month of 2021.

Biotech ETFs extend January gains

10:39am, Monday, 01'st Feb 2021
Biotech exchange-traded funds rallied Monday as investors continued to monitor the sector and its impact on the coronavirus pandemic. The ETFMG Treatments Testing and Advancement ETF gained 4.6% mid-m

Top-Performing ETFs of Last Week

09:06am, Monday, 01'st Feb 2021
Simple profit-booking and some warnings from the too-big-to-fail companies probably led to crash in Wall Street last week.

COVID-Themed ETFs in Focus Amid Soaring Cases

06:03pm, Wednesday, 13'th Jan 2021
The first half of 2021 is expected to continue bearing the brunt of the coronavirus outbreak. Thus, a COVID-themed ETF could be a smart pick.

First Vaccine ETF Should See Halcyon Days Ahead

02:05pm, Tuesday, 10'th Nov 2020
There was big news on the coronavirus vaccine front Monday when Pfizer (NYSE: PFE) and BioNTech (NASDAQ: BNTX) said their vaccine delivered an impressive showing in Phase 3 trials. What Happened: Alo

Why investors are turning to COVID-19 themed ETFs

04:12pm, Wednesday, 12'th Aug 2020
ETF Managers Group launched its biotech ETF GERM. ETF Managers Group CEO Sam Masucci joins the On the Move panel to discuss.
The last piece of news from iBio (NYSEMKT:IBIO) was the June 26 press release letting investors know that IBIO stock had been added to the Russell 2000 and Russell 3000 indexes as part of FTSE Russell
The GERM ETF offers exposure to some of the talked about names among biotechs developing/marketing treatments, vaccines and diagnostics for COVID-19. GERM favou

The Reopening Killed The V-Shaped Recovery

07:43am, Monday, 29'th Jun 2020
This is a weekly series focused on analyzing the previous week’s economic data releases. The objective is to concentrate on leading indicators of economic activ
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE